company

APOTEK 1 ULVEN AS

0581 OSLO

Return on Equity
50,97 %
Current Ratio
1,49
Debt-to-Equity Ratio
0,06
Key figures (NOK)2022
Revenue10 067 000
Net Income975 000
Total Assets3 987 000
Total Equity1 913 000
Income (NOK)2022
Revenue10 067 000
Expenditure8 789 000
Operating Profit1 278 000
Financial Income10 000
Financial Costs37 000
Financial Balance−27 000
Earnings Before Tax1 251 000
Tax276 000
Net Income975 000
Balance (NOK)2022
Total Fixed Assets1 078 000
Total Current Assets2 909 000
Total Assets3 987 000
Total Retained Equity1 883 000
Total Equity1 913 000
Total Long-Term Debt117 000
Total Current Debt1 958 000
Total Equity and Debt3 987 000
Cash flow (NOK)2022
Sales Income10 067 000
Other Income0
Revenue10 067 000
Cost of Goods Sold7 061 000
Salary Costs768 000
Depreciation177 000
Impairment0
Expenditure8 789 000
Operating Profit1 278 000
Financial Income10 000
Financial Costs37 000
Financial Balance−27 000
Dividends0
Net Income975 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures927 000
Total Tangible Assets927 000
Total Fiancial Fixed Assets150 000
Total Fixed Assets1 078 000
Stock853 000
Total Investments0
Cash, Bank1 729 000
Total Current Assets2 909 000
Total Assets3 987 000
Total Equity1 913 000
Short-Term Group Debt0
Total Long-Term Debt117 000
Creditors1 015 000
Unpaid Taxes181 000
Dividends0
Other Current Debt485 000
Total Current Debt1 958 000
Total Equity and Debt3 987 000
Financial indicators2022
Return on Equity50,97 %
Debt-to-Equity Ratio0,06
Operating Profit Margin12,69 %
Current Ratio1,49
Quick Ratio2,63
Equity Ratio0,48
Gross Profit Margin29,86 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English